Baoqiang Cao
Overview
Explore the profile of Baoqiang Cao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
188
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu J, Hu J, Xu H, Yan L, Yao J, Cao B
Iran J Basic Med Sci
. 2025 Jan;
28(1):87-97.
PMID: 39877630
Objectives: Exploring the role of VDAC1 in hepatocyte apoptosis during acute liver injury induced by obstructive jaundice. Materials And Methods: Animal and cell models were established to investigate possible mechanisms...
2.
Xiang L, Hu J, Yan X, Yang H, Ji C, Xu Y, et al.
Adv Healthc Mater
. 2024 Jun;
14(4):e2401708.
PMID: 38875524
Despite laparoscopic-guided minimally invasive hepatectomy emerging as the primary approach for resecting hepatocellular carcinoma (HCC), there is still a significant gap in suitable biomaterials that seamlessly integrate with these techniques...
3.
Wang W, Liu D, Yao J, Yuan Z, Yan L, Cao B
Med Sci Monit
. 2024 Jun;
30:e943523.
PMID: 38824386
BACKGROUND Hepatocellular carcinoma (HCC) poses a significant threat to human life and is the most prevalent form of liver cancer. The intricate interplay between apoptosis, a common form of programmed...
4.
Wu W, Yan X, Chen S, Du Y, Hu J, Song Y, et al.
Adv Mater
. 2024 Mar;
36(26):e2309770.
PMID: 38447017
Percutaneous thermotherapy, a minimally invasive operational procedure, is employed in the ablation of deep tumor lesions by means of target-delivering heat. Conventional thermal ablation methods, such as radiofrequency or microwave...
5.
Peng J, Li H, Tong F, Hu J, Li M, Chen G, et al.
Epigenomics
. 2024 Mar;
PMID: 38444389
To explore the overall methylation changes in liver tissues during the formation of gallstones, as well as the key pathways and genes involved in the process. Reduced-representation bisulfite sequencing and...
6.
Gong J, Hu J, Yan X, Xiang L, Chen S, Yang H, et al.
Small
. 2023 Jul;
20(3):e2300733.
PMID: 37452437
Relapse and unresectability have become the main obstacle for further improving hepatocellular carcinoma (HCC) treatment effect. Currently, single therapy for HCC in clinical practice is limited by postoperative recurrence, intraoperative...
7.
Chen S, Song Y, Yan X, Dong L, Xu Y, Xuan S, et al.
J Nanobiotechnology
. 2022 Aug;
20(1):381.
PMID: 35986283
Bioactive materials have been extensively developed for the adjuvant therapy of cancer. However, few materials can meet the requirements for the postoperative resection of hepatocellular carcinoma (HCC) due to massive...
8.
Chen G, Li M, Cao B, Xu Q, Zhang Z
Wideochir Inne Tech Maloinwazyjne
. 2022 Jun;
17(2):303-308.
PMID: 35707332
Introduction: In some cases, laparoscopic cholecystectomy (LC) may be very difficult and easily converted to laparotomy, causing many complications to patients and prolonging the prognosis time. Thus, to evaluate the...
9.
Yan X, Sun T, Song Y, Peng W, Xu Y, Luo G, et al.
Nano Lett
. 2022 Mar;
22(6):2251-2260.
PMID: 35254836
Current surgical single modality treatments for hepatocellular carcinoma (HCC) were restricted by recurrence, blood loss, significant trauma, and poor prognostic. Although multidisciplinary strategies for HCC treatment have been highly recommended...
10.
Yin M, Hu J, Yuan Z, Luo G, Yao J, Wang R, et al.
Cell Cycle
. 2022 Feb;
21(8):767-779.
PMID: 35130108
This study aimed to explore the role of a stimulator of interferon (IFN) gene (STING) agonist in breast cancer (BCa) immunotherapy. Clinical samples were collected from 37 patients with BCa....